+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CRF-41 stimulates the release of beta-lipotrophin and beta-endorphin in normal human subjects

CRF-41 stimulates the release of beta-lipotrophin and beta-endorphin in normal human subjects

Neuroendocrinology 38(4): 282-284

A prompt rise in circulating immunoreactive N- and C-terminal lipotrophin (LPH) accompanied the increase in ACTH when 100 micrograms CRF-41 was given to 6 normal male subjects. Chromatography of the basal and peak 15-min values showed that there was an equimolar increase in beta-LPH and beta-endorphin, to cause parallel release of ACTH, beta-endorphin and beta-LPH from the pro-opiocortin precursor.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 042429168

Download citation: RISBibTeXText

PMID: 6328343

Related references

Crf-41 Stimulates the Release of -Lipotrophin and -Endorphin in Normal Human Subjects. Neuroendocrinology 38(4): 282-284, 1984

Beta-lipotrophin in human plasma and cerebrospinal fluid: radioimmunoassay evidence for gamma-lipotrophin and beta-endorphin. Journal of Endocrinology 77(2): 27p-28p, 1978

beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects. Journal of Clinical Endocrinology and Metabolism 60(3): 485-489, 1985

Maternal and cord plasma concentrations of beta-lipotrophin, beta-endorphin and gamma-lipotrophin at delivery; effect of analgesia. British Journal of Obstetrics and Gynaecology 90(12): 1152-1156, 1983

Maternal plasma concentrations of beta-lipotrophin, beta-endorphin and gamma-lipotrophin throughout pregnancy. British Journal of Obstetrics and Gynaecology 90(12): 1147-1151, 1983

Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary gland. Journal of Endocrinology 96(3): 395-400, 1983

Localization and concentrations of beta-endorphin and beta-lipotrophin in human placenta. Placenta 8(4): 381-388, 1987

Discrimination between beta-endorphin and beta-lipotrophin in human plasma using two-site immunoradiometric assays. Clinical Endocrinology 39(4): 445-453, 1993

Presence of immunoreactive beta-endorphin in normal human plasma: a concomitant release of beta-endorphin with adrenocorticotropin after metyrapone administration. Journal of Clinical Investigation 62(6): 1395-1398, 1978

Beta-endorphin and beta-lipotrophin in human ovary. Neuropeptides 8(3): 251-258, 1986

Biosynthesis and release of beta-endorphin-, N-acetyl beta-endorphin-, beta-endorphin-(1-27)-, and N-acetyl beta-endorphin-(1-27)-like peptides by rat pituitary neurointermediate lobe: beta-endorphin is not further processed by anterior lobe. Journal of Neuroscience 1(6): 585-595, 1981

Resistance exercise and plasma beta-endorphin/beta-lipotrophin immunoreactivity. Life Sciences 34(6): 515-518, 1984

Effects of Pituitary Beta-Endorphin Secretagogues on the Concentration of Beta-Endorphin in Rat Cerebrospinal Fluid: Evidence for a Role of Vasopressin in the Regulation of Brain Beta-Endorphin Release. Neuroendocrinology 51(1): 104-110, 1990

Effects of pituitary beta-endorphin secretagogues on the concentration of beta-endorphin in rat cerebrospinal fluid: evidence for a role of vasopressin in the regulation of brain beta-endorphin release. Neuroendocrinology 51(1): 104-110, 1990

beta-lipotrophin and beta-endorphin plasma levels during pregnancy. Clinical Endocrinology 14(4): 409-418, 1981